Physician profile
James Eric Layton
NPI 1134417108
$2,033.28
in general payments reported to CMS, 2019-2025
14 companies · $757 in 2025
The $757 reported for 2025 was more than what 94% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.34 · 2020: $233 · 2021: $39.46 · 2022: $661 · 2023: $271 · 2024: $34.47 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787 · Education: $147 · Gift: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.92 |
| Education | $146.86 |
| Gift | $128.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $573.84 | 2022 | |
| Patterson Companies, INC. | $383.59 | 2021-2025 | |
| Kerr Corporation | $237.43 | 2019-2023 | Maxcem Elite |
| Biohorizons Implant Systems INC. | $163.74 | 2020-2023 | Biohorizons |
| Straumann USA LLC | $150.48 | 2025 | |
| Ultradent Products INC | $128.49 | 2025 | Opalescence |
| Envista Holdings Corporation | $127.84 | 2025 | Maxcem Elite, Zirconia Abutment Preparation Kit |
| Colgate Oral Pharmaceuticals, INC. | $91.77 | 2020 | |
| Nobel Biocare USA | $62.01 | 2023 | Nobelactive |
| Ormco Corporation | $46.44 | 2023 | Spark |
| Align Technology, INC. | $23.25 | 2025 | Invisalign |
| Henry Schein, INC. | $17.17 | 2024 | |
| Peter Brasseler Holdings, LLC | $15.10 | 2022 | |
| Philips North America LLC | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Layton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.